Regulation of gap-junction protein connexin 43 by beta-adrenergic receptor stimulation in rat cardiomyocytes

Acta Pharmacol Sin. 2009 Jul;30(7):928-34. doi: 10.1038/aps.2009.92.

Abstract

Aim: beta-adrenergic receptor (beta-AR) agonists are among the most potent factors regulating cardiac electrophysiological properties. Connexin 43 (Cx43), the predominant gap-junction protein in the heart, has an indispensable role in modulating cardiac electric activities by affecting gap-junction function. The present study investigates the effects of short-term stimulation of beta-AR subtypes on Cx43 expression and gap junction intercellular communication (GJIC) function.

Methods: The level of Cx43 expression in neonatal rat cardiomyocytes (NRCM) was detected by a Western blotting assay. The GJIC function was evaluated by scrape loading/dye transfer assay.

Results: Stimulation of beta-AR by the agonist isoproterenol for 5 min induces the up-regulation of nonphosphorylated Cx43 protein level, but not total Cx43. Selective beta(2)-AR inhibitor ICI 118551, but not beta(1)-AR inhibitor CGP20712, could fully abolish the effect. Moreover, pretreatment with both protein kinase A inhibitor H89 and G(i) protein inhibitor pertussis toxin also inhibited the isoproterenol-induced increase of nonphosphorylated Cx43 expression. Isoproterenol-induced up-regulation of nonphosphorylated Cx43 is accompanied with enhanced GJIC function.

Conclusion: Taken together, beta(2)-AR stimulation increases the expression of nonphosphorylated Cx43, thereby enhancing the gating function of gap junctions in cardiac myocytes in both a protein kinase A- and G(i)-dependent manner.Acta Pharmacologica Sinica (2009) 30: 928-934; doi: 10.1038/aps.2009.92.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Animals, Newborn
  • Cells, Cultured
  • Connexin 43 / genetics
  • Connexin 43 / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • GTP-Binding Protein alpha Subunits, Gi-Go / metabolism
  • Gap Junctions / metabolism*
  • Humans
  • Imidazoles / pharmacology
  • Isoproterenol / pharmacology
  • Myocytes, Cardiac / cytology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Pertussis Toxin / metabolism
  • Propranolol / pharmacology
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Protein Phosphatase 2 / antagonists & inhibitors
  • Protein Phosphatase 2 / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, beta / genetics
  • Receptors, Adrenergic, beta / metabolism*
  • Signal Transduction / physiology

Substances

  • Adrenergic beta-Agonists
  • Adrenergic beta-Antagonists
  • Connexin 43
  • Imidazoles
  • Protein Isoforms
  • Receptors, Adrenergic, beta
  • Propranolol
  • CGP 20712A
  • Pertussis Toxin
  • Cyclic AMP-Dependent Protein Kinases
  • Ppp2ca protein, rat
  • Protein Phosphatase 2
  • GTP-Binding Protein alpha Subunits, Gi-Go
  • Isoproterenol